Anagliptin Improved HbA1c Added to Metformin and Empagliflozin Tags hBA1c DPP-4 inhibitors Biguanide SGLT-2 Inhibitor Read more about Anagliptin Improved HbA1c Added to Metformin and Empagliflozin
Finerenone Benefit Persisted Across Baseline Diabetes Care Goals Tags Lipoprotein(a) hBA1c GLP-1 agonists SGLT-2 Inhibitor Read more about Finerenone Benefit Persisted Across Baseline Diabetes Care Goals
TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM Tags Myocardial infarction Peripheral vascular disease Stroke DPP-4 inhibitors Thiazolidinediones Read more about TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM
Oral Semaglutide 25 mg Matched SC Exposure in Obesity With and Without T2DM Tags GLP-1 agonists Read more about Oral Semaglutide 25 mg Matched SC Exposure in Obesity With and Without T2DM
Tirzepatide Outperformed Dulaglutide for MACE in T2DM With ASCVD Tags Coronary artery disease GLP-1 agonists Read more about Tirzepatide Outperformed Dulaglutide for MACE in T2DM With ASCVD
NAION Risk Increased After GLP-1 RA Start in T2DM Tags Nonarteritic Ischemic Optic Neuropathy GLP-1 agonists DPP-4 inhibitors Read more about NAION Risk Increased After GLP-1 RA Start in T2DM
Semaglutide Showed Strong Metabolic Benefits in Schizophrenia Tags GLP-1 agonists Read more about Semaglutide Showed Strong Metabolic Benefits in Schizophrenia
Global Safety Review Flags Drug-Specific Risks With GLP-1 RAs Tags GLP-1 agonists Read more about Global Safety Review Flags Drug-Specific Risks With GLP-1 RAs
Semaglutide Lowered Insulin Dose in Type 1 Diabetes with Obesity Tags GLP-1 agonists Read more about Semaglutide Lowered Insulin Dose in Type 1 Diabetes with Obesity
GLP-1 RAs Use Show Higher NAION Risk in Meta-Analysis Tags Nonarteritic Ischemic Optic Neuropathy GLP-1 agonists Read more about GLP-1 RAs Use Show Higher NAION Risk in Meta-Analysis